Insider Transactions Reported by 12 Insiders of Bellerophon Therapeutics, Inc.

Location
Warren, NJ

There are no Buy or Sell transactions made by insiders since 12 Mar 2025

Bellerophon Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Peter Fernandes Chief Executive Officer, Principal Financial and Accounting Officer $310,000 07 Jun 2023
Nicholas Laccona Financial Officer, (Pfo & Pao) $155,000 10 Feb 2023
Parag Suresh Shah VP of Business Operations $155,000 07 Jun 2023
Martin Dekker VP of Engineering & Manufacturing $155,000 07 Jun 2023
Bobae Kim VP Reg. Affairs & Quality $155,000 07 Jun 2023
PCM Ai Opportunities Fund 10%+ Owner $111,776 07 Jun 2023
Scott P. Bruder Director $45,282 07 Jun 2023
Mary Ann Cloyd Director $45,282 07 Jun 2023
Crispin Teufel Director $45,282 07 Jun 2023
Wang Theodore T. Director $45,282 07 Jun 2023
Naseem Amin Director $30,296 07 Jun 2023
Puissance Capital Management LP 10%+ Owner 13 Oct 2023

Recent Insider Transactions by Companies or Individuals for Bellerophon Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Puissance Capital Management LP Common Stock Sale -100% $111,776 $0.1038 -1,076,841 0 13 Oct 2023 Direct
Naseem Amin Common Stock Award 19.5% 47,578 291,865 07 Jun 2023 Direct
Peter Fernandes Stock Options (Right to Buy) Award -50% -100,000 100,000 07 Jun 2023 Direct
Parag Suresh Shah Stock Options (Right to Buy) Award -50% -50,000 50,000 07 Jun 2023 Direct
Martin Dekker Stock Options (Right to Buy) Award -50% -50,000 50,000 07 Jun 2023 Direct
Bobae Kim Stock Options (Right to Buy) Award -50% -50,000 50,000 07 Jun 2023 Direct
Theodore T. Wang Stock Options (Right to Buy) Award -50% -14,607 14,607 07 Jun 2023 Direct
Mary Ann Cloyd Stock Options (Right to Buy) Award -50% -14,607 14,607 07 Jun 2023 Direct
Crispin Teufel Stock Options (Right to Buy) Award -50% -14,607 14,607 07 Jun 2023 Direct
Puissance Life Science Opportunities Fund VI Common Stock Sale -11.1% $111,569 $0.8300 -134,421 1,076,841 07 Jun 2023 Direct
Scott P. Bruder Stock Options (Right to Buy) Award -50% -14,607 14,607 07 Jun 2023 Direct
Bobae Kim Common Stock Options Exercise 296.1% 1,288 1,723 18 May 2023 Direct
Bobae Kim Common Stock Sale -84.6% -9,455 1,723 18 May 2023 Direct
Bobae Kim Stock Options (Right to Buy) Options Exercise -87.6% -1,022 144 18 May 2023 Direct
Bobae Kim Stock Options (Right to Buy) Options Exercise -100% -266 0 18 May 2023 Direct
Puissance Life Science Opportunities Fund VI Common Stock Sale -31.6% -560,000 1,211,262 18 May 2023 Direct
Naseem Amin Common Stock Award 52.4% 84,000 244,287 10 Feb 2023 Direct
Crispin Teufel Stock Options (right to buy) Award 29,000 29,000 10 Feb 2023 Direct
Martin Dekker Stock Options (right to buy) Award 50,000 50,000 10 Feb 2023 Direct
Parag Suresh Shah Stock Options (right to buy) Award 50,000 50,000 10 Feb 2023 Direct
Peter Fernandes Stock Options (right to buy) Award 100,000 100,000 10 Feb 2023 Direct
Nicholas Laccona Stock Options (right to buy) Award 50,000 50,000 10 Feb 2023 Direct
Mary Ann Cloyd Stock Options (right to buy) Award 29,000 29,000 10 Feb 2023 Direct
Theodore T. Wang Stock Options (right to buy) Award 29,000 29,000 10 Feb 2023 Direct
Scott P. Bruder Stock Options (right to buy) Award 29,000 29,000 10 Feb 2023 Direct
Martin Dekker Common Stock Options Exercise 25,500 25,500 09 Dec 2022 Direct
Martin Dekker Common Stock Tax liability -30.7% -7,834 17,666 09 Dec 2022 Direct
Martin Dekker Restricted Stock Units Options Exercise -50% -25,500 25,500 09 Dec 2022 Direct
Peter Fernandes Common Stock Tax liability -30.7% -9,985 22,515 09 Dec 2022 Direct
Peter Fernandes Common Stock Options Exercise 32,500 32,500 09 Dec 2022 Direct
Peter Fernandes Restricted Stock Units Options Exercise -50% -32,500 32,500 09 Dec 2022 Direct
Parag Suresh Shah Common Stock Options Exercise 25,500 25,500 09 Dec 2022 Direct
Parag Suresh Shah Common Stock Tax liability -30.7% -7,834 17,666 09 Dec 2022 Direct
Parag Suresh Shah Restricted Stock Units Options Exercise -50% -25,500 25,500 09 Dec 2022 Direct
Nicholas Laccona Common Stock Options Exercise 18,000 18,000 09 Dec 2022 Direct
Nicholas Laccona Common Stock Tax liability -30.7% -5,530 12,470 09 Dec 2022 Direct
Nicholas Laccona Restricted Stock Units Options Exercise -50% -18,000 18,000 09 Dec 2022 Direct
Peter Fernandes Restricted Stock Units Award 65,000 65,000 26 Jan 2022 Direct
Martin Dekker Restricted Stock Units Award 51,000 51,000 26 Jan 2022 Direct
Parag Suresh Shah Restricted Stock Units Award 51,000 51,000 26 Jan 2022 Direct
Nicholas Laccona Restricted Stock Units Award 36,000 36,000 26 Jan 2022 Direct
Theodore T. Wang Stock Options (right to buy) Award 158.1% 21,828 35,634 31 Dec 2021 Direct
Crispin Teufel Stock Options (right to buy) Award 193.9% 21,828 33,087 31 Dec 2021 Direct
Mary Ann Cloyd Stock Options (right to buy) Award 150.8% 21,828 36,300 31 Dec 2021 Direct
Naseem Amin Common Stock Award 32.2% 39,032 160,287 31 Dec 2021 Direct
Naseem Amin Stock Options (right to buy) Award 57.3% 8,671 23,809 31 Dec 2021 Direct
Scott P. Bruder Stock Options (right to buy) Award 144.2% 21,828 36,966 31 Dec 2021 Direct
Puissance Life Science Opportunities Fund VI Common Stock Award 0.46% 8,189 1,771,262 07 Jun 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.